Eliem Therapeutics, Inc.
ELYM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13 | -$9 | -$21 | -$14 |
| Dep. & Amort. | $0 | $1 | -$1 | -$1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $1 | $2 | $3 |
| Change in WC | $0 | $0 | $0 | -$3 |
| Other Non-Cash | -$3 | -$4 | $4 | $2 |
| Operating Cash Flow | -$12 | -$11 | -$15 | -$12 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$24 | -$21 | -$59 | -$132 |
| Inv. Sales/Matur. | $39 | $25 | $16 | -$30 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $15 | $5 | -$43 | -$162 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$9 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $2 |
| Financing Cash Flow | $0 | $0 | $0 | $2 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | $3 | -$6 | -$58 | -$136 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23 | $29 | $87 | $223 |
| End Cash | $26 | $23 | $29 | $87 |
| Free Cash Flow | -$12 | -$11 | -$15 | -$12 |